Tag: pharmaceutical industry

Defining relevant markets in the pharmaceutical industry

Expert Economist George Siotis authored an article for Concurrences in which he argues that, in abuse proceedings involving both foreclosure and exploitative abuse, defining relevant markets conditional on the nature of the infringement offers a cogent framework. The insights also transpose to mergers. Abstract Art 102 proceedings require concomitance: the incriminated undertaking must be deemed dominant at the time … Continued